Brief: Ligand Prices $400 Million Convertible Senior Notes Offering
12/08/2025 04:47
Aug 11 (Reuters) - Ligand Pharmaceuticals Inc LGND.O: LIGAND ANNOUNCES PRICING OF $400 MILLION CONVERTIBLE SENIOR NOTES OFFERING Source text: ID:nGNXccswtl Further company coverage: LGND.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ligand Pharmaceuticals Incorporated
See all newsBrief: Ligand Acquires Royalty And Milestone Interest In Santen’s Ryjunea From Sydnexis For $23 Million
Ligand Pharmaceuticals Incorporated reports results for the quarter ended June 30 - Earnings Summary
Ligand Pharmaceuticals Q2 revenue rises on royalty growth
Brief: Ligand Pharmaceuticals Q2 EPS USD 2.22
U.S. RESEARCH ROUNDUP-Equinix, Goldman Sachs, JPMorgan